News from the healthcare data industry
Vivalink platform’s ability to deliver uninterrupted streams of real-world physiological data enables faster algorithm development for disease detection and diagnosis CAMPBELL, Calif., April 12, 2022 /PRNewswire/ — Vivalink, a leading provider of digital...
ZURICH, April 12, 2022 /PRNewswire/ — BC Platforms (BCP), a global leader in health care data management and analytics, today announced a partnership with analytics leader SAS to support customers in health care and...
SAN FRANCISCO, April 12, 2022 (GLOBE NEWSWIRE) — Specialty Networks, the largest provider of community urology, gastroenterology, and rheumatology care performance and population health analytics, and Datavant, the leader in...
An expert from trial tech specialist Komodo Health talks about how real-world evidence use could elevate study design, conserve costs, and improve recruitment. Read More: https://www.outsourcing-pharma.com/Article/2022/04/13/rwe-can-boost-trial-acceleration-cost-efficiency-and-inclusivity?utm_source=copyright&utm_medium=OnSite&utm_campaign=copyright
Underrepresentation of racial minorities in clinical trials for cancer and other diseases isn’t new; there has been a significant dearth in the representation of minorities in oncology trials for years....
Accenture has deepened its partnership with Palantir, a leading data analytics software firm, with the creation of a new innovation center. Accenture Applied Intelligence – the consulting firm’s practice focusing on...
April 11, 2022 By Bio-IT World Staff April 11, 2022 | Bio-IT World today announced the 2022 Innovative Practices Awards winners. Four grand prize awards were granted to AstraZeneca, Guardant Health with IQVIA,...
NEW YORK and SAN FRANCISCO, April 11, 2022 (GLOBE NEWSWIRE) — Komodo Health, a technology company driving patient-centric insights at scale, and Datavant, the leader in helping organizations securely connect...
ABSTRACT BACKGROUND AND AIMS: The impact of the COVID-19 pandemic on patients with inflammatory bowel disease [IBD] is largely unknown. We characterized the impact of COVID-19 on IBD care by...
The founder and CEO of Sensyne Health plc is to leave the Oxford company. Labour peer Lord Drayson, who founded the company in 2018 to accelerate the role of artificial...